In recent case reports, autoantibodies against myositis, such as anti-MDA5, anti-SAE, anti-Mi2, anti-Ku, and anti-Ro52, have been detected in COVID-19 patients with DM. This evidence concerns the gene IFIH1 and COVID-19.